Similar articles

• Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers.

  Metcalfe K, Lynch HT, Foulkes WD, Tung N, Kim-Sing C, Olopade OI, Eisen A, Rosen B, Snyder C, Gershman S, Sun P, Narod SA. Metcalfe K, et al. JAMA Oncol. 2015 Jun;1(3):306-13. doi: 10.1001/jamaoncol.2015.0658. JAMA Oncol. 2015. PMID: 26181175
• Does oophorectomy reduce breast cancer mortality for BRCA mutation carriers after breast cancer?

  Jacobson M, Narod SA. Jacobson M, et al. Expert Rev Anticancer Ther. 2018 Apr;18(4):305-306. doi: 10.1080/14737140.2018.1438891. Epub 2018 Feb 16. Expert Rev Anticancer Ther. 2018. PMID: 29431530 No abstract available.
• Cost-effectiveness of surveillance and prevention strategies in BRCA1/2 mutation carriers.

  Yamauchi H, Nakagawa C, Kobayashi M, Kobayashi Y, Mano T, Nakamura S, Arai M. Yamauchi H, et al. Breast Cancer. 2018 Mar;25(2):141-150. doi: 10.1007/s12282-017-0803-y. Epub 2017 Oct 10. Breast Cancer. 2018. PMID: 29019095
• Risk-reducing salpingo-oophorectomy in patients with germline mutations in BRCA1 or BRCA2.

  Kauff ND, Barakat RR. Kauff ND, et al. J Clin Oncol. 2007 Jul 10;25(20):2921-7. doi: 10.1200/JCO.2007.11.3449. J Clin Oncol. 2007. PMID: 17617523 Review.
• Management updates for women with a BRCA1 or BRCA2 mutation.

  Nusbaum R, Isaacs C. Nusbaum R, et al. Mol Diagn Ther. 2007;11(3):133-44. doi: 10.1007/BF03256234. Mol Diagn Ther. 2007. PMID: 17570734 Review.